Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | PALB2 K16M PALB2 Y551* |
| Therapy | Cisplatin |
| Indication/Tumor Type | Advanced Solid Tumor |
| Response Type | no benefit |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| PALB2 K16M PALB2 Y551* | Advanced Solid Tumor | no benefit | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, expressing PALB2 K16M did not sensitize transformed human cells harboring PALB2 Y551* to Platinol (cisplatin) treatment in culture (PMID: 35853885). | 35853885 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (35853885) | Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. | Full reference... |